French skincare manufacturer ACM Laboratoire Dermatologique officially presented two new hyperpigmentation products, Depiwhite Serum and Depiwhite Dietary Capsules, in the Dominican Republic on August 10, 2026.
The French laboratory unveiled the items during the 7th Ordinary Meeting of the Dominican Society of Dermatology in Santo Domingo. The annual gathering is one of the nation's premier scientific conferences, bringing together skin specialists to analyze diagnostic and therapeutic advances in dermatology.
The official launch expands the firm's established Depiwhite product range. Company leaders said the line establishes an integrated approach to skin spots by pairing topical dermatological treatments with oral dietary supplementation.
Depigmentation therapy evidence
As part of the scientific conference program, Dr. Sonia Read delivered a keynote presentation titled Inside-Out Depigmentation: Enhancing results with oral and topical therapy. Her lecture detailed the scientific foundation and clinical trial evidence supporting combined topical and oral therapies for hyperpigmentation management.
Read emphasized the importance of treating skin pigmentation disorders from a dual perspective. She said acting simultaneously on the skin's surface and from within the body significantly enhances overall therapeutic results for patients.
Depiwhite Serum is an intensive depigmenting concentrate formulated to reduce existing spots, help prevent new hyperpigmentation, and unify skin tone. Its patented formulation targets multiple biological mechanisms involved in skin pigmentation and is designated for use on the face, neck, chest, and hands.
Depiwhite Dietary Capsules complement topical therapies from the inside. The oral supplement combines grape and rose extracts, zinc, and vitamins C, E, and B3 to support broader dermatological treatments.
Endocrine disorders and skin conditions
Dr. Sherezade Hasbun also addressed attendees at the gathering, presenting a lecture titled Endocrinopathies and skin conditions. Her session examined the direct relationship between various endocrine disorders and their dermatological symptoms.
Hasbun noted that numerous endocrine diseases produce early manifestations on the skin. As a result, patients frequently consult a dermatologist before ever seeing an endocrinologist.
Among the specific conditions discussed, Hasbun highlighted diabetes mellitus and obesity, which are frequently linked to acanthosis nigricans. She explained that this skin alteration can range in presentation from barely perceptible patches to prominent skin lesions.
Conference organizers noted that adding these clinical lectures to the official agenda expanded discussion around cutaneous alterations and reinforced the necessity of evaluating patients holistically.
Laboratory operations and distribution
Selecting the Dominican Society of Dermatology's meeting as the launch venue reflects the company's objective to support continuing medical education and keep healthcare specialists informed of new clinical alternatives.
ACM Laboratoire Dermatologique is an international French laboratory focused on creating evidence-based dermatological solutions. The firm manufactures products for skin, hair, and scalp care sold across international markets.
In the Dominican Republic, Gencasa serves as the exclusive distributor for ACM Laboratoire Dermatologique products. Gencasa operates as a specialized distributor of dermatological solutions while supporting continuous medical education initiatives for health professionals across the country.
